Railway Traction Motor Market: Global Market Size, Trends, Competitive, Historical and
Forecast Analysis, 2020–2030. Increase in the number of railway projects, railway logistics,
and electrification in conventional railways are expected to fuel the railway traction motor
The Global Railway Traction Motor Market size was valued at USD 33.69 billion in 2019 and
is projected to reach 47.64 billion by 2030, growing at a CAGR of 3.2% from 2020 to 2030.
Traction motor is an electric motor used to generate the power for rotating the wheels of a
train. These motors are widely used in railways due to its high performance and greater
durability. The traction motor provides high torque at low speed and vice versa that acts as
a key driver for the market growth and propulsion. Also, the development in railroad
technologies and stringent regulations pertaining to vehicular emissions in countries around
the world are expected to boosts the market growth. Moreover, increased demand of metro
and mono rails for better transport within the city coupled with expanding tourism industry
is expected to further fuel the growth of railway traction motor market. However, high
investment for designing and manufacturing traction motors may hinder the railways
traction motors market growth.
Access Full Description of this report at:-
Top Companies: Integra Lifesciences Corporation, AbbVie Inc., Merck KGaA, Medtronic,
Thermo Fisher Scientific Inc., Smith+Nephew, Becton, Dickinson and Company, Baxter
International Inc, Cook Biotech, and Organogenesis Inc and others.
The global railway traction motor market is segmented based on type, application, and
geography. On the basis of type, the market is classified into DC traction motor, AC traction
motor, and synchronous AC traction motor. By application, it is categorized into diesel
locomotive, electric multiple units, electric locomotives, diesel electric locomotives.
Geographically, it is ana